Search Results 8161-8170 of 34448 for oral
... Oral and throat cancer, Salivary gland cancer, Thyroid cancer, Head and neck cancer, Skin cancer, Thyroid nodule, Salivary gland tumor, Laryngeal cancer ...
Patients receiving oral anticoagulants, as well as those with an acquired or congenital coagulopathy, are at increased risk for ICH and hemorrhagic ...
Skipping periods as you approach menopause — a stage sometimes called perimenopause — is common and expected. During that time, menstrual periods often will ...
Women who are using oral contraceptives, other hormonal contraceptives (vaginal products, skin patches, or implanted or injectable products), or mechanical ...
Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...
Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...
Current use of exogenous hormones (i.e., oral progesterone). Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...
Giving carfilzomib together with dexamethasone may be an effective treatment for multiple myeloma. Phase 2 Study to Evaluate the Oral ... Oral Decitabine ( ...
Ability to swallow and tolerate oral tablets. Females of childbearing potential must have a negative pregnancy test. The following laboratory parameters ...
Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.